Takeda Pharmaceutical Company Limited announced candidates for its Board of Directors and a change in representative director at the 150th Ordinary General Meeting of Shareholders on June 24, 2026. Julie Kim is proposed as new internal director to become Representative Director, President & CEO, succeeding Christophe Weber who will retire, with new external directors Bruce Broussard, Koichiro Kimura, and Paul Stoffels proposed.
Key takeaways
Board proposes Julie Kim as new internal director and Representative Director, President & CEO effective June 24, 2026
Christophe Weber to retire as Representative Director, President & CEO on June 24, 2026
New external director candidates: Bruce Broussard, Koichiro Kimura, Paul Stoffels
Retiring external directors: Jean Luc Butel, Ian Clark, Yoshiaki Fujimori, Koji Hatsukawa, Emiko Higashi, Michel Orsinger
Shareholders meeting: 150th Ordinary General Meeting on June 24, 2026
All other current Board members proposed for re-election